Xtant Medical Holdings (XTNT) Retained Earnings (2010 - 2025)
Xtant Medical Holdings' (XTNT) quarterly Retained Earnings came in at $305.4 million in Q4 2025, up 217.72% year-on-year from $96.1 million in Q4 2024, and up 220.0% on a QoQ basis from -$254.5 million in Q3 2025.
Xtant Medical Holdings (XTNT) Retained Earnings (2010 - 2025) Analysis & Trends
Xtant Medical Holdings (XTNT) has 16 years of Retained Earnings data on file, last reported at $305.4 million in Q4 2025.
- On a quarterly basis, Retained Earnings rose 217.72% year-over-year to $305.4 million in Q4 2025; TTM through Dec 2025 was $305.4 million, a 217.72% increase from a year earlier, with the FY2025 full-year figure at $305.4 million, up 217.72% from the prior year.
- Retained Earnings for Q4 2025 stood at $305.4 million, up from -$254.5 million in the prior quarter.
- Over the last five years, Retained Earnings for XTNT reached as high as $305.4 million in Q4 2025 and fell as low as -$259.5 million in Q4 2024.
- Historically, Retained Earnings has averaged $75.7 million across 5 years, with a median of $264.4 million in 2021.
- Across the five-year window, Retained Earnings slumped 175444.52% in 2024 and jumped 217.72% in 2025, its largest moves.
- Year by year, Retained Earnings stood at $266.1 million in 2021, then rose by 4.42% to $277.8 million in 2022, then grew by 5.93% to $294.3 million in 2023, then plunged by 188.15% to -$259.5 million in 2024, then soared by 217.72% to $305.4 million in 2025.
- Per Business Quant data, the three most recent Retained Earnings figures were $305.4 million in Q4 2025, -$254.5 million in Q3 2025, and -$255.9 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -6.31 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -583.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | -4.10 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 6.91 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 14.62 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 2.63 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -1.40 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 5.32 Bn |
| 10 | Xtant Medical Holdings | 5.69 Mn | -11.63 Mn | 17.75 Mn | 305.44 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 305.44 Mn |
| Sep 30, 2025 | -254.54 Mn |
| Jun 30, 2025 | -255.85 Mn |
| Mar 31, 2025 | -209,000.00 |
| Dec 31, 2024 | -259.46 Mn |
| Sep 30, 2024 | -256.30 Mn |
| Jun 30, 2024 | -175,000.00 |
| Mar 31, 2024 | -247.41 Mn |
| Dec 31, 2023 | 294.33 Mn |
| Sep 30, 2023 | -146,000.00 |
| Jun 30, 2023 | 278.90 Mn |
| Mar 31, 2023 | 278.46 Mn |
| Dec 31, 2022 | 277.84 Mn |
| Sep 30, 2022 | -241.46 Mn |
| Jun 30, 2022 | 267.25 Mn |
| Mar 31, 2022 | 266.68 Mn |
| Dec 31, 2021 | 266.07 Mn |
| Sep 30, 2021 | 265.54 Mn |
| Jun 30, 2021 | 264.98 Mn |
| Mar 31, 2021 | 263.73 Mn |